nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—HTR2C—choroid plexus—systemic lupus erythematosus	0.0589	0.273	CbGeAlD
Duloxetine—HTR2A—choroid plexus—systemic lupus erythematosus	0.0295	0.137	CbGeAlD
Duloxetine—CYP1A2—urine—systemic lupus erythematosus	0.0101	0.0469	CbGeAlD
Duloxetine—NPY1R—cortex of kidney—systemic lupus erythematosus	0.00892	0.0414	CbGeAlD
Duloxetine—HTR2A—urine—systemic lupus erythematosus	0.0079	0.0367	CbGeAlD
Duloxetine—SLC6A4—blood plasma—systemic lupus erythematosus	0.00779	0.0362	CbGeAlD
Duloxetine—CYP2D6—urine—systemic lupus erythematosus	0.0072	0.0334	CbGeAlD
Duloxetine—NPY1R—lung—systemic lupus erythematosus	0.00649	0.0301	CbGeAlD
Duloxetine—NPY1R—nervous system—systemic lupus erythematosus	0.00601	0.0279	CbGeAlD
Duloxetine—NPY1R—central nervous system—systemic lupus erythematosus	0.00579	0.0269	CbGeAlD
Duloxetine—CYP1A2—blood plasma—systemic lupus erythematosus	0.00527	0.0245	CbGeAlD
Duloxetine—HTR2A—endothelium—systemic lupus erythematosus	0.00464	0.0216	CbGeAlD
Duloxetine—HTR6—nervous system—systemic lupus erythematosus	0.00423	0.0196	CbGeAlD
Duloxetine—HTR2A—blood plasma—systemic lupus erythematosus	0.00412	0.0191	CbGeAlD
Duloxetine—HTR6—central nervous system—systemic lupus erythematosus	0.00407	0.0189	CbGeAlD
Duloxetine—CYP2D6—blood plasma—systemic lupus erythematosus	0.00376	0.0174	CbGeAlD
Duloxetine—SLC6A3—lung—systemic lupus erythematosus	0.00273	0.0127	CbGeAlD
Duloxetine—SLC6A3—nervous system—systemic lupus erythematosus	0.00253	0.0117	CbGeAlD
Duloxetine—SLC6A4—lung—systemic lupus erythematosus	0.0025	0.0116	CbGeAlD
Duloxetine—HTR2C—nervous system—systemic lupus erythematosus	0.00244	0.0114	CbGeAlD
Duloxetine—SLC6A3—central nervous system—systemic lupus erythematosus	0.00243	0.0113	CbGeAlD
Duloxetine—HTR2C—central nervous system—systemic lupus erythematosus	0.00235	0.0109	CbGeAlD
Duloxetine—SLC6A4—nervous system—systemic lupus erythematosus	0.00232	0.0108	CbGeAlD
Duloxetine—SLC6A4—central nervous system—systemic lupus erythematosus	0.00223	0.0104	CbGeAlD
Duloxetine—SLC6A2—lung—systemic lupus erythematosus	0.0022	0.0102	CbGeAlD
Duloxetine—HTR2A—connective tissue—systemic lupus erythematosus	0.0022	0.0102	CbGeAlD
Duloxetine—SLC6A2—nervous system—systemic lupus erythematosus	0.00204	0.00947	CbGeAlD
Duloxetine—SLC6A2—central nervous system—systemic lupus erythematosus	0.00196	0.00912	CbGeAlD
Duloxetine—HTR2A—kidney—systemic lupus erythematosus	0.00187	0.00868	CbGeAlD
Duloxetine—CYP2D6—kidney—systemic lupus erythematosus	0.0017	0.00791	CbGeAlD
Duloxetine—CYP1A2—lung—systemic lupus erythematosus	0.00169	0.00786	CbGeAlD
Duloxetine—HTR2A—tendon—systemic lupus erythematosus	0.00151	0.00701	CbGeAlD
Duloxetine—HTR2A—lung—systemic lupus erythematosus	0.00132	0.00615	CbGeAlD
Duloxetine—HTR2A—nervous system—systemic lupus erythematosus	0.00123	0.00569	CbGeAlD
Duloxetine—HTR2A—central nervous system—systemic lupus erythematosus	0.00118	0.00548	CbGeAlD
Duloxetine—CYP2D6—nervous system—systemic lupus erythematosus	0.00112	0.00519	CbGeAlD
Duloxetine—CYP2D6—central nervous system—systemic lupus erythematosus	0.00108	0.00499	CbGeAlD
Duloxetine—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000319	0.000416	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000319	0.000416	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000319	0.000415	CcSEcCtD
Duloxetine—Pain—Hydrocortisone—systemic lupus erythematosus	0.000318	0.000415	CcSEcCtD
Duloxetine—Oedema—Dexamethasone—systemic lupus erythematosus	0.000318	0.000414	CcSEcCtD
Duloxetine—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000318	0.000414	CcSEcCtD
Duloxetine—Oedema—Betamethasone—systemic lupus erythematosus	0.000318	0.000414	CcSEcCtD
Duloxetine—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000318	0.000414	CcSEcCtD
Duloxetine—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000317	0.000413	CcSEcCtD
Duloxetine—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000316	0.000412	CcSEcCtD
Duloxetine—Infection—Betamethasone—systemic lupus erythematosus	0.000316	0.000412	CcSEcCtD
Duloxetine—Infection—Dexamethasone—systemic lupus erythematosus	0.000316	0.000412	CcSEcCtD
Duloxetine—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000315	0.00041	CcSEcCtD
Duloxetine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000315	0.00041	CcSEcCtD
Duloxetine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000314	0.000409	CcSEcCtD
Duloxetine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000314	0.000409	CcSEcCtD
Duloxetine—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000314	0.000409	CcSEcCtD
Duloxetine—Anaemia—Prednisone—systemic lupus erythematosus	0.000314	0.000409	CcSEcCtD
Duloxetine—Shock—Dexamethasone—systemic lupus erythematosus	0.000313	0.000408	CcSEcCtD
Duloxetine—Shock—Betamethasone—systemic lupus erythematosus	0.000313	0.000408	CcSEcCtD
Duloxetine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000312	0.000406	CcSEcCtD
Duloxetine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000312	0.000406	CcSEcCtD
Duloxetine—Agitation—Prednisone—systemic lupus erythematosus	0.000312	0.000406	CcSEcCtD
Duloxetine—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000311	0.000406	CcSEcCtD
Duloxetine—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000311	0.000406	CcSEcCtD
Duloxetine—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.00031	0.000404	CcSEcCtD
Duloxetine—Tachycardia—Betamethasone—systemic lupus erythematosus	0.00031	0.000404	CcSEcCtD
Duloxetine—Angioedema—Prednisone—systemic lupus erythematosus	0.00031	0.000404	CcSEcCtD
Duloxetine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000309	0.000402	CcSEcCtD
Duloxetine—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000309	0.000402	CcSEcCtD
Duloxetine—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000308	0.000401	CcSEcCtD
Duloxetine—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000308	0.000401	CcSEcCtD
Duloxetine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000307	0.000401	CcSEcCtD
Duloxetine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000307	0.000401	CcSEcCtD
Duloxetine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000307	0.0004	CcSEcCtD
Duloxetine—Malaise—Prednisone—systemic lupus erythematosus	0.000306	0.000399	CcSEcCtD
Duloxetine—Vertigo—Prednisone—systemic lupus erythematosus	0.000305	0.000397	CcSEcCtD
Duloxetine—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000304	0.000397	CcSEcCtD
Duloxetine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000304	0.000397	CcSEcCtD
Duloxetine—Syncope—Prednisone—systemic lupus erythematosus	0.000304	0.000397	CcSEcCtD
Duloxetine—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000304	0.000396	CcSEcCtD
Duloxetine—Anorexia—Betamethasone—systemic lupus erythematosus	0.000303	0.000395	CcSEcCtD
Duloxetine—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000303	0.000395	CcSEcCtD
Duloxetine—Urticaria—Prednisolone—systemic lupus erythematosus	0.000303	0.000395	CcSEcCtD
Duloxetine—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000302	0.000394	CcSEcCtD
Duloxetine—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000302	0.000394	CcSEcCtD
Duloxetine—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000302	0.000393	CcSEcCtD
Duloxetine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000301	0.000392	CcSEcCtD
Duloxetine—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000301	0.000392	CcSEcCtD
Duloxetine—Pain—Triamcinolone—systemic lupus erythematosus	0.0003	0.000391	CcSEcCtD
Duloxetine—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000298	0.000389	CcSEcCtD
Duloxetine—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000296	0.000386	CcSEcCtD
Duloxetine—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000296	0.000385	CcSEcCtD
Duloxetine—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000296	0.000385	CcSEcCtD
Duloxetine—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000294	0.000383	CcSEcCtD
Duloxetine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000294	0.000383	CcSEcCtD
Duloxetine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000294	0.000383	CcSEcCtD
Duloxetine—Convulsion—Prednisone—systemic lupus erythematosus	0.000294	0.000383	CcSEcCtD
Duloxetine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000294	0.000383	CcSEcCtD
Duloxetine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000293	0.000382	CcSEcCtD
Duloxetine—Hypertension—Prednisone—systemic lupus erythematosus	0.000293	0.000382	CcSEcCtD
Duloxetine—Chills—Methotrexate—systemic lupus erythematosus	0.000292	0.000381	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.00029	0.000378	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.00029	0.000378	CcSEcCtD
Duloxetine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000289	0.000377	CcSEcCtD
Duloxetine—Myalgia—Prednisone—systemic lupus erythematosus	0.000289	0.000377	CcSEcCtD
Duloxetine—Arthralgia—Prednisone—systemic lupus erythematosus	0.000289	0.000377	CcSEcCtD
Duloxetine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000289	0.000376	CcSEcCtD
Duloxetine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000288	0.000376	CcSEcCtD
Duloxetine—Anxiety—Prednisone—systemic lupus erythematosus	0.000288	0.000375	CcSEcCtD
Duloxetine—Alopecia—Methotrexate—systemic lupus erythematosus	0.000288	0.000375	CcSEcCtD
Duloxetine—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000288	0.000375	CcSEcCtD
Duloxetine—Insomnia—Betamethasone—systemic lupus erythematosus	0.000288	0.000375	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000287	0.000374	CcSEcCtD
Duloxetine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000287	0.000373	CcSEcCtD
Duloxetine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000286	0.000373	CcSEcCtD
Duloxetine—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000286	0.000372	CcSEcCtD
Duloxetine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000286	0.000372	CcSEcCtD
Duloxetine—Discomfort—Prednisone—systemic lupus erythematosus	0.000285	0.000372	CcSEcCtD
Duloxetine—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000285	0.000372	CcSEcCtD
Duloxetine—Erythema—Methotrexate—systemic lupus erythematosus	0.000284	0.00037	CcSEcCtD
Duloxetine—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000284	0.00037	CcSEcCtD
Duloxetine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000281	0.000366	CcSEcCtD
Duloxetine—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.00028	0.000365	CcSEcCtD
Duloxetine—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.00028	0.000365	CcSEcCtD
Duloxetine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.00028	0.000364	CcSEcCtD
Duloxetine—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000278	0.000363	CcSEcCtD
Duloxetine—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000278	0.000362	CcSEcCtD
Duloxetine—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000278	0.000362	CcSEcCtD
Duloxetine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000277	0.000361	CcSEcCtD
Duloxetine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000277	0.000361	CcSEcCtD
Duloxetine—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000277	0.000361	CcSEcCtD
Duloxetine—Oedema—Prednisone—systemic lupus erythematosus	0.000277	0.000361	CcSEcCtD
Duloxetine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000276	0.00036	CcSEcCtD
Duloxetine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000276	0.00036	CcSEcCtD
Duloxetine—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000276	0.00036	CcSEcCtD
Duloxetine—Infection—Prednisone—systemic lupus erythematosus	0.000275	0.000359	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000275	0.000358	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000275	0.000358	CcSEcCtD
Duloxetine—Back pain—Methotrexate—systemic lupus erythematosus	0.000274	0.000358	CcSEcCtD
Duloxetine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000274	0.000357	CcSEcCtD
Duloxetine—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000274	0.000357	CcSEcCtD
Duloxetine—Fatigue—Betamethasone—systemic lupus erythematosus	0.000274	0.000357	CcSEcCtD
Duloxetine—Shock—Prednisone—systemic lupus erythematosus	0.000273	0.000355	CcSEcCtD
Duloxetine—Pain—Dexamethasone—systemic lupus erythematosus	0.000272	0.000354	CcSEcCtD
Duloxetine—Pain—Betamethasone—systemic lupus erythematosus	0.000272	0.000354	CcSEcCtD
Duloxetine—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000272	0.000354	CcSEcCtD
Duloxetine—Tachycardia—Prednisone—systemic lupus erythematosus	0.00027	0.000352	CcSEcCtD
Duloxetine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.00027	0.000352	CcSEcCtD
Duloxetine—Skin disorder—Prednisone—systemic lupus erythematosus	0.000269	0.000351	CcSEcCtD
Duloxetine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000268	0.000349	CcSEcCtD
Duloxetine—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000267	0.000348	CcSEcCtD
Duloxetine—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000267	0.000348	CcSEcCtD
Duloxetine—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000266	0.000347	CcSEcCtD
Duloxetine—Rash—Cyclosporine—systemic lupus erythematosus	0.000264	0.000344	CcSEcCtD
Duloxetine—Anorexia—Prednisone—systemic lupus erythematosus	0.000264	0.000344	CcSEcCtD
Duloxetine—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000264	0.000344	CcSEcCtD
Duloxetine—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000263	0.000343	CcSEcCtD
Duloxetine—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000263	0.000343	CcSEcCtD
Duloxetine—Headache—Cyclosporine—systemic lupus erythematosus	0.000262	0.000342	CcSEcCtD
Duloxetine—Anaemia—Methotrexate—systemic lupus erythematosus	0.000262	0.000342	CcSEcCtD
Duloxetine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000262	0.000342	CcSEcCtD
Duloxetine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000262	0.000342	CcSEcCtD
Duloxetine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.00026	0.000339	CcSEcCtD
Duloxetine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.00026	0.000339	CcSEcCtD
Duloxetine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.00026	0.000339	CcSEcCtD
Duloxetine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000258	0.000337	CcSEcCtD
Duloxetine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000258	0.000336	CcSEcCtD
Duloxetine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000258	0.000336	CcSEcCtD
Duloxetine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000257	0.000335	CcSEcCtD
Duloxetine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000256	0.000334	CcSEcCtD
Duloxetine—Malaise—Methotrexate—systemic lupus erythematosus	0.000256	0.000333	CcSEcCtD
Duloxetine—Vertigo—Methotrexate—systemic lupus erythematosus	0.000255	0.000332	CcSEcCtD
Duloxetine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000255	0.000332	CcSEcCtD
Duloxetine—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000254	0.000331	CcSEcCtD
Duloxetine—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000253	0.000329	CcSEcCtD
Duloxetine—Urticaria—Betamethasone—systemic lupus erythematosus	0.000253	0.000329	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000252	0.000329	CcSEcCtD
Duloxetine—Dizziness—Prednisolone—systemic lupus erythematosus	0.000252	0.000328	CcSEcCtD
Duloxetine—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000251	0.000328	CcSEcCtD
Duloxetine—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000251	0.000328	CcSEcCtD
Duloxetine—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000251	0.000328	CcSEcCtD
Duloxetine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000251	0.000328	CcSEcCtD
Duloxetine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000251	0.000328	CcSEcCtD
Duloxetine—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000251	0.000327	CcSEcCtD
Duloxetine—Insomnia—Prednisone—systemic lupus erythematosus	0.000251	0.000326	CcSEcCtD
Duloxetine—Nausea—Cyclosporine—systemic lupus erythematosus	0.000249	0.000324	CcSEcCtD
Duloxetine—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000249	0.000324	CcSEcCtD
Duloxetine—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000248	0.000323	CcSEcCtD
Duloxetine—Cough—Methotrexate—systemic lupus erythematosus	0.000248	0.000323	CcSEcCtD
Duloxetine—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000247	0.000322	CcSEcCtD
Duloxetine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000246	0.000321	CcSEcCtD
Duloxetine—Convulsion—Methotrexate—systemic lupus erythematosus	0.000246	0.00032	CcSEcCtD
Duloxetine—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000244	0.000318	CcSEcCtD
Duloxetine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000243	0.000316	CcSEcCtD
Duloxetine—Chest pain—Methotrexate—systemic lupus erythematosus	0.000241	0.000315	CcSEcCtD
Duloxetine—Myalgia—Methotrexate—systemic lupus erythematosus	0.000241	0.000315	CcSEcCtD
Duloxetine—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000241	0.000315	CcSEcCtD
Duloxetine—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000241	0.000314	CcSEcCtD
Duloxetine—Rash—Prednisolone—systemic lupus erythematosus	0.00024	0.000313	CcSEcCtD
Duloxetine—Dermatitis—Prednisolone—systemic lupus erythematosus	0.00024	0.000313	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.00024	0.000312	CcSEcCtD
Duloxetine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000239	0.000312	CcSEcCtD
Duloxetine—Fatigue—Prednisone—systemic lupus erythematosus	0.000239	0.000311	CcSEcCtD
Duloxetine—Headache—Prednisolone—systemic lupus erythematosus	0.000239	0.000311	CcSEcCtD
Duloxetine—Discomfort—Methotrexate—systemic lupus erythematosus	0.000239	0.000311	CcSEcCtD
Duloxetine—Constipation—Prednisone—systemic lupus erythematosus	0.000237	0.000309	CcSEcCtD
Duloxetine—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000237	0.000308	CcSEcCtD
Duloxetine—Rash—Hydrocortisone—systemic lupus erythematosus	0.000235	0.000306	CcSEcCtD
Duloxetine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000235	0.000306	CcSEcCtD
Duloxetine—Confusional state—Methotrexate—systemic lupus erythematosus	0.000233	0.000304	CcSEcCtD
Duloxetine—Headache—Hydrocortisone—systemic lupus erythematosus	0.000233	0.000304	CcSEcCtD
Duloxetine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000232	0.000302	CcSEcCtD
Duloxetine—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000231	0.000302	CcSEcCtD
Duloxetine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000231	0.000301	CcSEcCtD
Duloxetine—Infection—Methotrexate—systemic lupus erythematosus	0.00023	0.0003	CcSEcCtD
Duloxetine—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000228	0.000297	CcSEcCtD
Duloxetine—Asthenia—Betamethasone—systemic lupus erythematosus	0.000228	0.000297	CcSEcCtD
Duloxetine—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000228	0.000297	CcSEcCtD
Duloxetine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000227	0.000296	CcSEcCtD
Duloxetine—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000227	0.000295	CcSEcCtD
Duloxetine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000226	0.000295	CcSEcCtD
Duloxetine—Nausea—Prednisolone—systemic lupus erythematosus	0.000226	0.000295	CcSEcCtD
Duloxetine—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000225	0.000293	CcSEcCtD
Duloxetine—Pruritus—Betamethasone—systemic lupus erythematosus	0.000225	0.000293	CcSEcCtD
Duloxetine—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000225	0.000293	CcSEcCtD
Duloxetine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000224	0.000292	CcSEcCtD
Duloxetine—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000223	0.00029	CcSEcCtD
Duloxetine—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000222	0.00029	CcSEcCtD
Duloxetine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000221	0.000288	CcSEcCtD
Duloxetine—Rash—Triamcinolone—systemic lupus erythematosus	0.000221	0.000288	CcSEcCtD
Duloxetine—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000221	0.000288	CcSEcCtD
Duloxetine—Anorexia—Methotrexate—systemic lupus erythematosus	0.000221	0.000288	CcSEcCtD
Duloxetine—Rash—Methylprednisolone—systemic lupus erythematosus	0.000221	0.000287	CcSEcCtD
Duloxetine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.00022	0.000287	CcSEcCtD
Duloxetine—Urticaria—Prednisone—systemic lupus erythematosus	0.00022	0.000287	CcSEcCtD
Duloxetine—Headache—Triamcinolone—systemic lupus erythematosus	0.00022	0.000286	CcSEcCtD
Duloxetine—Headache—Methylprednisolone—systemic lupus erythematosus	0.000219	0.000286	CcSEcCtD
Duloxetine—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000219	0.000285	CcSEcCtD
Duloxetine—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000219	0.000285	CcSEcCtD
Duloxetine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000218	0.000284	CcSEcCtD
Duloxetine—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000218	0.000284	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000211	0.000275	CcSEcCtD
Duloxetine—Dizziness—Betamethasone—systemic lupus erythematosus	0.00021	0.000274	CcSEcCtD
Duloxetine—Dizziness—Dexamethasone—systemic lupus erythematosus	0.00021	0.000274	CcSEcCtD
Duloxetine—Insomnia—Methotrexate—systemic lupus erythematosus	0.000209	0.000273	CcSEcCtD
Duloxetine—Nausea—Triamcinolone—systemic lupus erythematosus	0.000208	0.000271	CcSEcCtD
Duloxetine—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000208	0.000271	CcSEcCtD
Duloxetine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000208	0.000271	CcSEcCtD
Duloxetine—Somnolence—Methotrexate—systemic lupus erythematosus	0.000206	0.000268	CcSEcCtD
Duloxetine—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000204	0.000266	CcSEcCtD
Duloxetine—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000204	0.000266	CcSEcCtD
Duloxetine—Vomiting—Betamethasone—systemic lupus erythematosus	0.000202	0.000264	CcSEcCtD
Duloxetine—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000202	0.000264	CcSEcCtD
Duloxetine—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000201	0.000262	CcSEcCtD
Duloxetine—Rash—Dexamethasone—systemic lupus erythematosus	0.000201	0.000261	CcSEcCtD
Duloxetine—Rash—Betamethasone—systemic lupus erythematosus	0.000201	0.000261	CcSEcCtD
Duloxetine—Dermatitis—Betamethasone—systemic lupus erythematosus	0.0002	0.000261	CcSEcCtD
Duloxetine—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.0002	0.000261	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.0002	0.00026	CcSEcCtD
Duloxetine—Fatigue—Methotrexate—systemic lupus erythematosus	0.0002	0.00026	CcSEcCtD
Duloxetine—Headache—Betamethasone—systemic lupus erythematosus	0.000199	0.00026	CcSEcCtD
Duloxetine—Headache—Dexamethasone—systemic lupus erythematosus	0.000199	0.00026	CcSEcCtD
Duloxetine—Asthenia—Prednisone—systemic lupus erythematosus	0.000199	0.000259	CcSEcCtD
Duloxetine—Pain—Methotrexate—systemic lupus erythematosus	0.000198	0.000258	CcSEcCtD
Duloxetine—Pruritus—Prednisone—systemic lupus erythematosus	0.000196	0.000255	CcSEcCtD
Duloxetine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000191	0.000249	CcSEcCtD
Duloxetine—Diarrhoea—Prednisone—systemic lupus erythematosus	0.00019	0.000247	CcSEcCtD
Duloxetine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000189	0.000247	CcSEcCtD
Duloxetine—Nausea—Betamethasone—systemic lupus erythematosus	0.000189	0.000246	CcSEcCtD
Duloxetine—Nausea—Dexamethasone—systemic lupus erythematosus	0.000189	0.000246	CcSEcCtD
Duloxetine—Urticaria—Methotrexate—systemic lupus erythematosus	0.000184	0.00024	CcSEcCtD
Duloxetine—Dizziness—Prednisone—systemic lupus erythematosus	0.000183	0.000239	CcSEcCtD
Duloxetine—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000183	0.000238	CcSEcCtD
Duloxetine—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000183	0.000238	CcSEcCtD
Duloxetine—Vomiting—Prednisone—systemic lupus erythematosus	0.000176	0.000229	CcSEcCtD
Duloxetine—Rash—Prednisone—systemic lupus erythematosus	0.000175	0.000228	CcSEcCtD
Duloxetine—Dermatitis—Prednisone—systemic lupus erythematosus	0.000174	0.000227	CcSEcCtD
Duloxetine—Headache—Prednisone—systemic lupus erythematosus	0.000174	0.000226	CcSEcCtD
Duloxetine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000171	0.000222	CcSEcCtD
Duloxetine—Asthenia—Methotrexate—systemic lupus erythematosus	0.000166	0.000216	CcSEcCtD
Duloxetine—Nausea—Prednisone—systemic lupus erythematosus	0.000165	0.000214	CcSEcCtD
Duloxetine—Pruritus—Methotrexate—systemic lupus erythematosus	0.000164	0.000213	CcSEcCtD
Duloxetine—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000158	0.000206	CcSEcCtD
Duloxetine—Dizziness—Methotrexate—systemic lupus erythematosus	0.000153	0.000199	CcSEcCtD
Duloxetine—Vomiting—Methotrexate—systemic lupus erythematosus	0.000147	0.000192	CcSEcCtD
Duloxetine—Rash—Methotrexate—systemic lupus erythematosus	0.000146	0.00019	CcSEcCtD
Duloxetine—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000146	0.00019	CcSEcCtD
Duloxetine—Headache—Methotrexate—systemic lupus erythematosus	0.000145	0.000189	CcSEcCtD
Duloxetine—Nausea—Methotrexate—systemic lupus erythematosus	0.000137	0.000179	CcSEcCtD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	3.42e-05	0.00198	CbGpPWpGaD
Duloxetine—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.37e-05	0.00196	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	3.34e-05	0.00194	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	3.34e-05	0.00194	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	3.33e-05	0.00193	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	3.32e-05	0.00192	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.31e-05	0.00192	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—P2RY12—systemic lupus erythematosus	3.29e-05	0.00191	CbGpPWpGaD
Duloxetine—HTR2A—G alpha (q) signalling events—F2—systemic lupus erythematosus	3.22e-05	0.00187	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—PRL—systemic lupus erythematosus	3.21e-05	0.00186	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CXCL12—systemic lupus erythematosus	3.18e-05	0.00184	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	3.15e-05	0.00183	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.15e-05	0.00182	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—EP300—systemic lupus erythematosus	3.05e-05	0.00177	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	3.03e-05	0.00176	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	3e-05	0.00174	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	3e-05	0.00174	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	2.98e-05	0.00173	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	2.97e-05	0.00172	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CCR5—systemic lupus erythematosus	2.96e-05	0.00171	CbGpPWpGaD
Duloxetine—SLC6A2—NRF2 pathway—TGFB1—systemic lupus erythematosus	2.94e-05	0.00171	CbGpPWpGaD
Duloxetine—SLC6A2—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.93e-05	0.0017	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	2.9e-05	0.00168	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—C3—systemic lupus erythematosus	2.89e-05	0.00168	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	2.88e-05	0.00167	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	2.86e-05	0.00166	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.86e-05	0.00166	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.84e-05	0.00165	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	2.8e-05	0.00162	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CXCL12—systemic lupus erythematosus	2.76e-05	0.0016	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	2.68e-05	0.00155	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	2.67e-05	0.00155	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.63e-05	0.00152	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.62e-05	0.00152	CbGpPWpGaD
Duloxetine—SLC6A3—NRF2 pathway—TGFB1—systemic lupus erythematosus	2.61e-05	0.00151	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	2.61e-05	0.00151	CbGpPWpGaD
Duloxetine—SLC6A3—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.6e-05	0.00151	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—JAK1—systemic lupus erythematosus	2.57e-05	0.00149	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—F2—systemic lupus erythematosus	2.54e-05	0.00147	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	2.53e-05	0.00147	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	2.48e-05	0.00144	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	2.46e-05	0.00142	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	2.45e-05	0.00142	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	2.44e-05	0.00141	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.44e-05	0.00141	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	2.44e-05	0.00141	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CCR5—systemic lupus erythematosus	2.43e-05	0.00141	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	2.43e-05	0.00141	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—P2RY12—systemic lupus erythematosus	2.42e-05	0.00141	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.4e-05	0.00139	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—IL2—systemic lupus erythematosus	2.38e-05	0.00138	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—C3—systemic lupus erythematosus	2.38e-05	0.00138	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	2.33e-05	0.00135	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.33e-05	0.00135	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	2.32e-05	0.00134	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	2.28e-05	0.00132	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CCL2—systemic lupus erythematosus	2.26e-05	0.00131	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	2.25e-05	0.0013	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCL12—systemic lupus erythematosus	2.22e-05	0.00128	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	2.19e-05	0.00127	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CCR5—systemic lupus erythematosus	2.18e-05	0.00126	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	2.13e-05	0.00124	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	2.13e-05	0.00123	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—C3—systemic lupus erythematosus	2.13e-05	0.00123	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—P2RY12—systemic lupus erythematosus	2.11e-05	0.00122	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—F2—systemic lupus erythematosus	2.09e-05	0.00121	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	2.07e-05	0.0012	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TLR9—systemic lupus erythematosus	2.01e-05	0.00116	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CD80—systemic lupus erythematosus	2e-05	0.00116	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—IL6—systemic lupus erythematosus	2e-05	0.00116	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.95e-05	0.00113	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	1.9e-05	0.0011	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CCR5—systemic lupus erythematosus	1.89e-05	0.0011	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—F2—systemic lupus erythematosus	1.87e-05	0.00108	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CCL2—systemic lupus erythematosus	1.86e-05	0.00108	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—C3—systemic lupus erythematosus	1.85e-05	0.00107	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.84e-05	0.00106	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	1.83e-05	0.00106	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	1.8e-05	0.00104	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CSK—systemic lupus erythematosus	1.79e-05	0.00104	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—JAK1—systemic lupus erythematosus	1.76e-05	0.00102	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TYK2—systemic lupus erythematosus	1.69e-05	0.000978	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	1.68e-05	0.000971	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.67e-05	0.000969	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CCL2—systemic lupus erythematosus	1.67e-05	0.000966	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—NOS3—systemic lupus erythematosus	1.66e-05	0.00096	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.65e-05	0.000955	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NCF2—systemic lupus erythematosus	1.64e-05	0.000949	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—C3—systemic lupus erythematosus	1.63e-05	0.000947	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCL12—systemic lupus erythematosus	1.63e-05	0.000945	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—LYN—systemic lupus erythematosus	1.63e-05	0.000942	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—F2—systemic lupus erythematosus	1.62e-05	0.000941	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.6e-05	0.000929	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.6e-05	0.000925	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	1.56e-05	0.000904	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.52e-05	0.000882	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.52e-05	0.00088	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.5e-05	0.000867	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.49e-05	0.000864	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—C3—systemic lupus erythematosus	1.48e-05	0.00086	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TLR9—systemic lupus erythematosus	1.48e-05	0.000857	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.47e-05	0.000854	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	1.46e-05	0.000843	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CCL2—systemic lupus erythematosus	1.45e-05	0.000839	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.44e-05	0.000832	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—F2—systemic lupus erythematosus	1.43e-05	0.000831	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.43e-05	0.00083	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	1.42e-05	0.000821	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL2—systemic lupus erythematosus	1.41e-05	0.000814	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—IL6—systemic lupus erythematosus	1.4e-05	0.00081	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.35e-05	0.000784	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—MMP9—systemic lupus erythematosus	1.33e-05	0.000771	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.33e-05	0.000768	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.32e-05	0.000766	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.32e-05	0.000765	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CSK—systemic lupus erythematosus	1.32e-05	0.000764	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	1.31e-05	0.00076	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.31e-05	0.000758	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—F2—systemic lupus erythematosus	1.3e-05	0.000755	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—JAK1—systemic lupus erythematosus	1.3e-05	0.000753	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—JUNB—systemic lupus erythematosus	1.28e-05	0.000744	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TLR9—systemic lupus erythematosus	1.28e-05	0.000744	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—EP300—systemic lupus erythematosus	1.26e-05	0.000731	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.24e-05	0.000721	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.23e-05	0.000714	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.22e-05	0.000707	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.21e-05	0.000703	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NCF2—systemic lupus erythematosus	1.21e-05	0.000699	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—C3—systemic lupus erythematosus	1.2e-05	0.000697	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—LYN—systemic lupus erythematosus	1.2e-05	0.000694	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.19e-05	0.000692	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PRL—systemic lupus erythematosus	1.18e-05	0.000686	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.18e-05	0.000684	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.17e-05	0.000681	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.17e-05	0.000681	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.16e-05	0.000673	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CSK—systemic lupus erythematosus	1.14e-05	0.000663	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	1.14e-05	0.00066	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	1.13e-05	0.000654	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.12e-05	0.000648	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.1e-05	0.000639	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.1e-05	0.000635	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—C3—systemic lupus erythematosus	1.09e-05	0.000633	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.07e-05	0.00062	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—F2—systemic lupus erythematosus	1.06e-05	0.000612	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.05e-05	0.000611	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.05e-05	0.000611	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NCF2—systemic lupus erythematosus	1.05e-05	0.000607	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—C3—systemic lupus erythematosus	1.05e-05	0.000606	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—LYN—systemic lupus erythematosus	1.04e-05	0.000603	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.02e-05	0.000594	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.02e-05	0.000591	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCR5—systemic lupus erythematosus	9.71e-06	0.000563	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.71e-06	0.000563	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—IL2—systemic lupus erythematosus	9.66e-06	0.00056	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.64e-06	0.000559	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—F2—systemic lupus erythematosus	9.59e-06	0.000556	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	9.57e-06	0.000555	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—C3—systemic lupus erythematosus	9.49e-06	0.00055	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—JAK1—systemic lupus erythematosus	9.47e-06	0.000549	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—JUNB—systemic lupus erythematosus	9.46e-06	0.000548	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—F2—systemic lupus erythematosus	9.17e-06	0.000532	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	9.11e-06	0.000528	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.99e-06	0.000521	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCR5—systemic lupus erythematosus	8.97e-06	0.00052	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL2RA—systemic lupus erythematosus	8.84e-06	0.000512	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL2—systemic lupus erythematosus	8.77e-06	0.000508	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—C3—systemic lupus erythematosus	8.77e-06	0.000508	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PRL—systemic lupus erythematosus	8.72e-06	0.000505	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL2—systemic lupus erythematosus	8.55e-06	0.000496	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.37e-06	0.000485	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—F2—systemic lupus erythematosus	8.33e-06	0.000483	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL6—systemic lupus erythematosus	8.26e-06	0.000479	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—JUNB—systemic lupus erythematosus	8.22e-06	0.000476	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.81e-06	0.000452	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—TYK2—systemic lupus erythematosus	7.77e-06	0.00045	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	7.71e-06	0.000447	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—F2—systemic lupus erythematosus	7.7e-06	0.000446	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PRL—systemic lupus erythematosus	7.57e-06	0.000439	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	7.43e-06	0.00043	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CD80—systemic lupus erythematosus	7.38e-06	0.000428	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—IL2—systemic lupus erythematosus	7.12e-06	0.000412	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—JAK1—systemic lupus erythematosus	6.97e-06	0.000404	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL2—systemic lupus erythematosus	6.86e-06	0.000397	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.74e-06	0.000391	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCR5—systemic lupus erythematosus	6.61e-06	0.000383	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.51e-06	0.000377	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL2—systemic lupus erythematosus	6.46e-06	0.000374	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—C3—systemic lupus erythematosus	6.46e-06	0.000374	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TYK2—systemic lupus erythematosus	6.23e-06	0.000361	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	6.18e-06	0.000358	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.13e-06	0.000355	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NOS3—systemic lupus erythematosus	6.11e-06	0.000354	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—JAK1—systemic lupus erythematosus	6.05e-06	0.000351	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCR5—systemic lupus erythematosus	5.74e-06	0.000332	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—F2—systemic lupus erythematosus	5.67e-06	0.000328	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.65e-06	0.000328	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL2—systemic lupus erythematosus	5.61e-06	0.000325	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—C3—systemic lupus erythematosus	5.61e-06	0.000325	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.51e-06	0.000319	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CD80—systemic lupus erythematosus	5.43e-06	0.000315	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.3e-06	0.000307	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL2—systemic lupus erythematosus	5.18e-06	0.0003	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL6—systemic lupus erythematosus	5.16e-06	0.000299	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	5.1e-06	0.000296	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL2—systemic lupus erythematosus	5.05e-06	0.000293	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—F2—systemic lupus erythematosus	4.92e-06	0.000285	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MMP9—systemic lupus erythematosus	4.91e-06	0.000284	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.89e-06	0.000283	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.82e-06	0.000279	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CD80—systemic lupus erythematosus	4.72e-06	0.000273	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—EP300—systemic lupus erythematosus	4.65e-06	0.00027	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TYK2—systemic lupus erythematosus	4.59e-06	0.000266	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NOS3—systemic lupus erythematosus	4.5e-06	0.000261	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.4e-06	0.000255	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	4.39e-06	0.000254	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	4.32e-06	0.000251	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.04e-06	0.000234	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.01e-06	0.000232	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	3.98e-06	0.000231	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	3.91e-06	0.000227	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.9e-06	0.000226	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL2—systemic lupus erythematosus	3.82e-06	0.000221	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL6—systemic lupus erythematosus	3.8e-06	0.00022	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MMP9—systemic lupus erythematosus	3.61e-06	0.000209	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.6e-06	0.000209	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—EP300—systemic lupus erythematosus	3.43e-06	0.000198	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.39e-06	0.000196	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	3.31e-06	0.000192	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	3.3e-06	0.000191	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.24e-06	0.000188	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	3.22e-06	0.000187	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.14e-06	0.000182	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.13e-06	0.000181	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL6—systemic lupus erythematosus	3.05e-06	0.000177	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.98e-06	0.000173	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	2.97e-06	0.000172	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	2.9e-06	0.000168	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.82e-06	0.000163	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	2.77e-06	0.000161	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	2.73e-06	0.000158	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.59e-06	0.00015	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	2.54e-06	0.000147	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	2.46e-06	0.000142	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	2.35e-06	0.000136	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL6—systemic lupus erythematosus	2.24e-06	0.00013	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.15e-06	0.000124	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	2.11e-06	0.000122	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	1.95e-06	0.000113	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.79e-06	0.000104	CbGpPWpGaD
